Instructions for use Taltz® 80 mg solution for injection in pre-filled pen ixekizumab Before using your pre-filled pen: Import
![Lillys Taltz® (v) Receives U.S. FDA Approval for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis Lillys Taltz® (v) Receives U.S. FDA Approval for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis](https://medicinaysaludpublica.blob.core.windows.net.optimalcdn.com/images/2021/02/24/lillys-taltz-v-receives-u-s-fda-approval-for-the-treatment-of-pediatric-patients-with-moderate-to-severe-plaque-psoriasis.jpg)
Lillys Taltz® (v) Receives U.S. FDA Approval for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis
INSTRUCTIONS FOR USE How to use the TALTZ prefilled autoinjector PrTALTZ® (ixekizumab) injection 80 mg/mL www.lilly.ca PLEASE R
Instructions for use Taltz® 80 mg solution for injection in pre-filled pen ixekizumab Before using your pre-filled pen: Import
INSTRUCTIONS FOR USE How to use the TALTZ prefilled autoinjector PrTALTZ® (ixekizumab) injection 80 mg/mL www.lilly.ca PLEASE R
INSTRUCTIONS FOR USE How to use the TALTZ prefilled autoinjector PrTALTZ® (ixekizumab) injection 80 mg/mL www.lilly.ca PLEASE R
Instructions for use Taltz® 80 mg solution for injection in pre-filled pen ixekizumab Before using your pre-filled pen: Import
![Lilly Announces Positive Top-Line Results for Taltz® (ixekizumab) vs. Humira® (adalimumab) in a Head-to-Head (SPIRIT-H2H) Superiority Study in Patients with Active Psoriatic Arthritis - iData Research Lilly Announces Positive Top-Line Results for Taltz® (ixekizumab) vs. Humira® (adalimumab) in a Head-to-Head (SPIRIT-H2H) Superiority Study in Patients with Active Psoriatic Arthritis - iData Research](https://idataresearch.com/wp-content/uploads/2018/12/taltz_lilly.png)